Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in ...

Dietary approaches are shaping up as a key aspect of chronic obstructive pulmonary disease (COPD) management.

Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

Chronic obstructive pulmonary disease (COPD) refers to a collection of lung diseases that can lead to blocked airways. This can make it hard to breathe and cause coughing, wheezing, and mucus ...

WebMD's COPD Health Center provides in-depth information on chronic obstructive pulmonary disease including symptoms, causes, treatment options, diagnosis, and tests.

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

A comprehensive meta-analysis of over 4.3 million adults shows e-cigarette use is associated with significantly higher odds ...

Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...